Lab
f2 similarity factor (dissolution)
TL;DR
The f2 similarity factor (FDA/CDER & EMA) compares two dissolution profiles point-by-point: f2 = 50·log{[1 + (1/n)Σ(Rt−Tt)²]^−0.5 × 100}. f2 ≥ 50 (i.e., average difference ≤10%) declares the profiles equivalent. For supplements with bioavailability claims or post-approval chan...
The f2 similarity factor (FDA/CDER & EMA) compares two dissolution profiles point-by-point: f2 = 50·log{[1 + (1/n)Σ(Rt−Tt)²]^−0.5 × 100}. f2 ≥ 50 (i.e., average difference ≤10%) declares the profiles equivalent. For supplements with bioavailability claims or post-approval changes (excipient swap, supplier change, scale-up), f2 is the pragmatic before/after equivalence test that avoids a clinical study.
Regulatory anchors
- FDA SUPAC-IR
- EMA Bioequivalence Guideline
How V5 handles it
QMS — quality engineered into every action, not bolted on.
Because V5 owns the operator action, the QMS sees the data the second it’s captured — not at the end of the shift.
Document control with hard kiosk-level training enforcement.
Versioned SOPs are only useful if operators are actually trained on the current version. V5 enforces it at the kiosk.
Related terms
Want to see f2 similarity factor (dissolution) in V5?
Free trial, no credit card, onboard in days, not months.